(Q42722130)

5 November 2017

Preferences of patients with advanced colorectal cancer for treatment with oral or intravenous chemotherapy (English)

1 reference

5 November 2017

1 reference

1 reference

10

Claudia Sandomenico

1 reference

5 November 2017

Candida M Mastroianni

1

1 reference

5 November 2017

Caterina Viscomi

2

1 reference

5 November 2017

Silvia Ceniti

3

1 reference

5 November 2017

Rosanna De Simone

4

1 reference

5 November 2017

Aldo Filice

5

1 reference

5 November 2017

Gennaro Gadaleta Caldarola

6

1 reference

5 November 2017

Stefania Infusino

7

1 reference

5 November 2017

Caterina Manfredi

8

1 reference

5 November 2017

Antonio Rea

9

1 reference

5 November 2017

Salvatore Turano

11

1 reference

5 November 2017

Francesco Serranò

12

1 reference

5 November 2017

Giovanni Condemi

13

1 reference

5 November 2017

Carla Cortese

14

1 reference

5 November 2017

Tullia Prantera

15

1 reference

5 November 2017

Salvatore Palazzo

16

1 reference

5 November 2017

Gruppo Oncologico Calabrese Multidisciplinare (GOCaM)

17

1 reference

5 November 2017

1 July 2008

1 reference

The Patient: Patient-Centered Outcomes Research

5 November 2017

1 reference

5 November 2017

1

1 reference

5 November 2017

3

1 reference

5 November 2017

181-187

1 reference

https://scigraph.springernature.com/pub.10.2165/1312067-200801030-00005

5 November 2017

0 references

cites work

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

1 reference

12 December 2020

Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection

1 reference

12 December 2020

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

12 December 2020

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab.

1 reference

12 December 2020

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

1 reference

12 December 2020

Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial

1 reference

12 December 2020

Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy

1 reference

12 December 2020

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

12 December 2020

Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire.

1 reference

12 December 2020

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

12 December 2020

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

1 reference

12 December 2020

Capecitabine as adjuvant treatment for stage III colon cancer

1 reference

12 December 2020

A study of quality of life in cancer patients receiving palliative chemotherapy

1 reference

12 December 2020

Thrombotic complications of central venous catheters in cancer patients

1 reference

12 December 2020

A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy.

1 reference

12 December 2020

Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems

1 reference

12 December 2020

A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis

1 reference

12 December 2020

Quality of life after surgery for colorectal cancer: clinical implications of results from randomised trials

1 reference

12 December 2020

Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer

1 reference

12 December 2020

Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer

1 reference

12 December 2020

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

1 reference

12 December 2020

A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer

1 reference

12 December 2020

10.2165/1312067-200801030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

5 November 2017

1049349182

0 references

Fatcat ID

release_mpgddhim6vczdcofqv2njw7a5y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mpgddhim6vczdcofqv2njw7a5y

24 November 2022

mapped directly with Wikidata item

1 reference